CIK 0000883975 · Non-accelerated filer<br>Smaller reporting company
Microbot Medical Inc.
Sign in to watch- Ticker
- MBOT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943078125
- Phone
- 908-938-5561
- Business address
- 25 RECREATION PARK DR SUITE 108, HINGHAM, MA, 02043
- Former names
- Microbot Medical Inc., STEMCELLS INC, CYTOTHERAPEUTICS INC/DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-23 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +3,952 | 3,952 | ||
| 2019-10-23 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +3,952 | 3,952 | ||
| 2019-10-23 | Laxminarain Prattipati Director | Grant or award · Stock Option (Right to Buy) | +3,952 | 3,952 | ||
| 2019-10-23 | Waizer Yoav Zvi Director | Grant or award · Stock Option (Right to Buy) | +3,952 | 3,952 | ||
| 2019-01-21 | Laxminarain Prattipati Director | Grant or award · Stock Option (Right to Buy) | +2,326 | 2,326 | ||
| 2019-01-21 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +2,326 | 2,326 | ||
| 2019-01-21 | Bornstein Yoseph Director | Grant or award · Stock Option (Right to Buy) | +2,326 | 2,326 | ||
| 2019-01-21 | Waizer Yoav Zvi Director | Grant or award · Stock Option (Right to Buy) | +2,326 | 2,326 | ||
| 2019-01-21 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +2,326 | 2,326 | ||
| 2018-01-09 | Bornstein Yoseph Director | Sale | −35,000 | $1.06 | $37K | 4,530,409 |
| 2018-01-03 | Bornstein Yoseph Director | Sale | −2,868 | $1.01 | $3K | 4,565,409 |
| 2018-01-02 | Bornstein Yoseph Director | Sale | −42,132 | $1.01 | $43K | 4,568,277 |
| 2017-12-28 | Naim David Ben Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2017-12-27 | Bornstein Yoseph Director | Sale | −14,257 | $1.02 | $15K | 4,610,409 |
| 2017-12-26 | Bornstein Yoseph Director | Sale | −30,743 | $1.02 | $31K | 4,624,666 |
| 2017-12-20 | Bornstein Yoseph Director | Sale | −12,933 | $1.03 | $13K | 4,655,409 |
| 2017-12-19 | Bornstein Yoseph Director | Sale | −32,067 | $1.03 | $33K | 4,655,409 |
| 2017-12-13 | Bornstein Yoseph Director | Sale | −841 | $1.02 | $858 | 4,700,409 |
| 2017-12-12 | Bornstein Yoseph Director | Sale | −44,159 | $1.04 | $46K | 4,701,250 |
| 2017-12-06 | Waizer Yoav Zvi Director | Grant or award · Stock Option (Right to Buy) | +38,095 | 38,095 |
Page 5 of 6 · 114 trades